| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 5,933 | 3,539 |
| Net decrease in cash and cash equivalents, and restricted cash | -5,652 | -7,518 |
| Cash and cash equivalents at beginning of period | 33,554 | - |
| Cash and cash equivalents at end of period | 27,902 | - |
Axogen, Inc. (AXGN)
Axogen, Inc. (AXGN)